archer materials
- Home
- archer materials
Public
Opening a new frontier in treating Parkinson’s disease
- Review
- November 11, 2022
Is this the most hated company on the ASX?
- Review
- August 16, 2019
Latest Articles
Archer Materials delivers breakthrough proof-of-concept devices for quantum computing chip production
Driving Australia forward in the global arms race towards quantum computing accessibility, Australian semiconductor company Archer Materials (ASX: AXE) has successfully produced two proof-of-concept (POC) electrical devices that enhance the manufacturability of their 12CQ quantum computing chip. The two newly developed devices improve the detection and readout of quantum information from Archer’s proprietary spin material,
Read MorePublic
Archer begins new experiments for its lab-on-a-chip for kidney disease detection
According to the Australian Institute of Health and Welfare, there are more than 1.7 million Australians that live with the biomedical signs of chronic kidney disease. While not all will deteriorate to kidney failure, it leads to the 22,000 deaths annually which could be reduced from earlier detection and better management, an initiative launched by
Read MorePublic
Archer Materials advances Biochip technology with new design for manufacturing to be tested in Finland
Australian semiconductor company Archer Materials (ASX: AXE) has progressed its latest Biochip design to the next phase of development by dispatching it to the VTT Technical Research Centre of Finland Ltd (VTT) for manufacturing. The Biochip’s newest graphene field-effect transistor (gFET) design, which was announced in July 2024, marks a milestone in enhancing it’s functionality,
Read MorePublic
Archer unveils breakthrough testing method for graphene transistors to identify optimal stability and accuracy
Australian semiconductor company Archer Materials (ASX: AXE) has developed a novel graphene transistor test that will produce the most stable and accurate gFETs for future development activities and commercialisation of their biochip for the medical diagnostics industry. The new procedure, designed to scrutinise the gFET sensors under various conditions and electrical operation modes, was developed
Read MorePublic
Archer Materials gains global exposure at the World Economic Forum tech conference
Archer Materials (ASX: AXE), recognised as a global leader in emerging technologies, recently showcased its innovations at the World Economic Forum (WEF) conference in San Francisco. CEO Dr. Mohammad Choucair (pictured) presented on advanced manufacturing value chains, discussing the semiconductor industry, the future of quantum computing and AI, at the event attended by over 230
Read MorePublic
International graphene foundry validates Archer’s Biochip towards commercial fabrication
Australian semiconductor company Archer Materials (ASX: AXE) is one step closer to the commercialisation of their graphene-based Biochip, a recent design of which has been successfully manufactured by foundry partner Graphenea in Spain, carving a pathway towards its future production. The milestone advances Archer’s Biochip capabilities in access to commercial semiconductor production facilities for technologies
Read MorePublic
